Quick Answer
Sonoma Pharmaceuticals, Inc. reported Research And Development Expense of $1.81 million for the year ending 2025.
- Sonoma Pharmaceuticals, Inc. showed a decrease of -3.0% in Research And Development Expense from 2024 to 2025.
- This data is from Sonoma Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on June 17, 2025.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2012: $532.0 thousand | Q3 2012: $513.0 thousand | Q4 2012: $509.0 thousand | Q2 2013: $507.0 thousand | Q3 2013: $883.0 thousand | Q4 2013: $775.0 thousand | Q2 2014: $439.0 thousand | Q3 2014: $353.0 thousand | Q4 2014: $367.0 thousand | Q2 2015: $467.0 thousand | Q3 2015: $412.0 thousand | Q4 2015: $486.0 thousand | Q2 2016: $360.0 thousand | Q3 2016: $379.0 thousand | Q4 2016: $487.0 thousand | Q2 2017: $382.0 thousand | Q3 2017: $368.0 thousand | Q4 2017: $349.0 thousand | Q2 2018: $350.0 thousand | Q3 2018: $390.0 thousand | Q4 2018: $451.0 thousand | Q2 2019: $338.0 thousand | Q3 2019: $270.0 thousand | Q4 2019: $248.0 thousand | Q2 2020: $476.0 thousand | Q3 2020: -$85.0 thousand | Q4 2020: $33.0 thousand | Q2 2021: $84.0 thousand | Q3 2021: $10.0 thousand | Q4 2021: $26.0 thousand | Q2 2022: $206.0 thousand | Q3 2022: $200.0 thousand | Q4 2022: $0.00 | Q2 2023: $325.0 thousand | Q3 2023: $536.0 thousand | Q4 2023: $601.0 thousand | Q2 2024: $470.0 thousand | Q3 2024: $506.0 thousand | Q4 2024: $427.0 thousand | Q2 2025: $594.0 thousand | Q3 2025: $575.0 thousand | Q4 2025: $557.0 thousand.
- Over the full 15 years of available data (2011 to 2025), Sonoma Pharmaceuticals, Inc.'s Research And Development Expense has declined by 11.3%.
- Historical annual values: Fiscal year 2025: $1.81 million | Fiscal year 2024: $1.87 million | Fiscal year 2023: $207.0 thousand | Fiscal year 2022: $125.0 thousand | Fiscal year 2021: $555.0 thousand | Fiscal year 2020: $1.34 million | Fiscal year 2019: $1.52 million | Fiscal year 2018: $1.58 million | Fiscal year 2017: $1.58 million | Fiscal year 2016: $1.81 million | Fiscal year 2015: $1.53 million | Fiscal year 2014: $2.89 million | Fiscal year 2013: $2.22 million | Fiscal year 2012: $1.98 million | Fiscal year 2011: $2.05 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: